Amid India's Got Latent row, Samay Raina and five more individuals have landed in trouble again for their insensitive remarks on the controversial show.

Niagen Bioscience, Inc. (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the continued ...

Tempus AI, Inc. , a technology company leading the adoption of AI to advance precision medicine and patient care, has announced the launch of Notetaker, an AI-powered clinical assistant to aid ...

Registrational study in patients with tumor hyperinsulinism (HI) expected to commence mid-year. Designation underscores need for therapies to treat severe hypoglycemia in the onco ...

Continued oncology pipeline advancement with a strategic focus on two priority pan-tumor programs: next-generation immunomodulator BNT327, a bispecific antibody targeting PD-L1 and VEGF-A1, and mRNA c ...

BioNTech invites investors and the general public to join a conference call and webcast with investment analysts today, May 5, 2025, at 8:00 a.m. EDT (2:00 p.m. CEST) to report its financial results ...

In his new role as CFO at BioNTech, Ramón Zapata will ensure the Company's financial direction continues to align with BioNTech's strategy to become a multi-product company in the oncology field. In ...

Heart health has been linked to lower levels of NfL, a key biomarker of brain cell damage in Huntington’s disease. This ...

Results demonstrated favorable safety, injection feasibility, and encouraging oncologic outcomes in patients (n=22) with locally advanced or borderline resectable pancreatic cancer Median Overall ...

The Riverwalk, part of the Mountains-to-Sea Trail, winds along the Eno River right through town. This isn’t some afterthought path – it’s a gorgeous, wheelchair-accessible greenway that gives you ...

Researchers have revealed critical insights into how impaired mitochondrial dynamics and quality control mechanisms in skeletal muscle influence insulin sensitivity in patients with Type 2 Diabetes, ...